Advances in understanding the anti-inflammatory properties of IL-27.
about
Immune response and immunopathology during toxoplasmosisExploring the full spectrum of macrophage activationProtection and pathology during parasite infection: IL-10 strikes the balanceInterleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral propertiesThe myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 productionCD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLsThe role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.Timed action of IL-27 protects from immunopathology while preserving defense in influenzaTransfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejectionIL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.Genome-Wide Analyses of MicroRNA Profiling in Interleukin-27 Treated Monocyte-Derived Human Dendritic Cells Using Deep Sequencing: A Pilot Study.Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.T-cell exhaustion: characteristics, causes and conversion.IL-12 family cytokines: immunological playmakersRole of interleukin 10 transcriptional regulation in inflammation and autoimmune diseasegp130 at the nexus of inflammation, autoimmunity, and cancer.Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis.Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cellsIL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondiiCellular cytokine and chemokine responses to parasite antigens and fungus and mite allergens in children co-infected with helminthes and protozoa parasitesIL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in micePolymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infectionThe association between single nucleotide polymorphism in interleukin-27 gene and recurrent pregnancy loss in Iranian womenIL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.IFN-γ and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection.IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microgliaTolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner.Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells.The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovaniOntogeny and localization of the cells produce IL-2 in healthy animals.Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs.
P2860
Q24612341-46034B1C-1993-4E8A-80EB-C734ED27183AQ24653754-87164BCC-66BC-426E-B9CF-6AAC1B82FB8BQ27005837-5201EA24-2FDC-46A8-9F88-C3D4746BF98AQ28385082-BE76B9FF-EF1E-49FB-8853-B9CD48B13899Q28730911-8956795A-1AB3-498F-82BB-85562400BC84Q30430530-BD97F88F-969D-4874-A636-F2F2076AB67DQ33391782-868D9912-DAB2-4B70-96FB-3E6D03696DE0Q33583784-E5391AE3-41A9-4E2D-93D9-8A4D59E179B1Q33583883-09367EA9-1E71-4F25-9290-84741D6C2124Q33651440-EE21F73B-9995-4936-921E-D6A7BB0164C0Q33754839-15A2D6B3-CFE7-4D4E-B8A3-DE8361430B75Q33967201-FF1B7E45-F18F-48F6-AFBC-DA7639A19574Q34102010-8EF40722-A044-4BE3-998C-340ED5591990Q34153998-8E9FA51E-DEFA-4CA3-9DF7-687883BAFC5DQ34262223-A7F2A327-01A1-412E-8EFF-62DB8DD0A012Q34378756-7B25ABE4-6E7F-46B5-91BA-BC93FD93705CQ34482169-95B84820-B15E-4196-98CE-204D4E1E255EQ34580118-EE669AA8-8BE3-432E-98A6-2E993F33BAECQ34609504-C8BAA1D4-6880-48D9-992C-D4EC39909871Q34792941-AEB4D085-F262-470D-8A7D-4AB0E1EBF5B2Q35058854-62066DEE-2ED2-403F-AC22-D2EDF5C58B81Q35101914-26DAF265-C8E2-4853-BD94-4C8FC6E6A28FQ35122668-7B190D61-6E10-4D46-8F8D-FD7FBDFD259CQ35148364-6C2A7A2D-CB0A-455E-81C5-44690787E163Q35227723-49EB0AEA-61C7-4BB3-B260-30EDDECA638AQ35476662-988C1D4A-0E34-4D76-8077-AF4F4B981A0CQ35654119-6CA0E196-1FBB-4F6D-9992-344F4312D189Q35737807-A00AAE41-1DE0-4A51-975F-3160745447F3Q35763786-C98D1EBA-0D51-4A0D-9AA0-9E2FA69E8548Q35787352-C9262C19-FF4F-4BA4-988E-268E650AAD47Q35860851-1A723A26-0C21-4D12-9897-0FFC431EAF44Q35863341-D524FC2B-1908-4889-9CD0-2DE69F0ADF53Q36041805-A1ABDFF5-1D08-484B-B53B-E8EFE59410A3Q36228542-F3AA410B-05D4-43C7-AFBC-164AC8621449Q36333169-47CE3071-E637-4EA2-BF6B-87A5AD1D36DDQ36336588-CB9D4B4B-6CA9-4D9F-B255-2735D5537C4DQ36570892-67D26CF7-798E-43AB-9FC6-F00E8B911BA6Q36677867-9136050F-C7F0-45C0-8D62-6635B06CA49BQ36700629-B113E07D-4112-4C49-89D4-E124FE295F17Q36861764-E6DDF22B-37E9-4847-9635-E82DF1804E3D
P2860
Advances in understanding the anti-inflammatory properties of IL-27.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in understanding the anti-inflammatory properties of IL-27.
@en
Advances in understanding the anti-inflammatory properties of IL-27.
@nl
type
label
Advances in understanding the anti-inflammatory properties of IL-27.
@en
Advances in understanding the anti-inflammatory properties of IL-27.
@nl
prefLabel
Advances in understanding the anti-inflammatory properties of IL-27.
@en
Advances in understanding the anti-inflammatory properties of IL-27.
@nl
P2860
P1433
P1476
Advances in understanding the anti-inflammatory properties of IL-27.
@en
P2093
C A Hunter
J S Stumhofer
P2860
P304
P356
10.1016/J.IMLET.2008.01.011
P577
2008-03-03T00:00:00Z